CF Canada Urges Adoption of New Care Guidelines, Access to Trikafta

CF Canada Urges Adoption of New Care Guidelines, Access to Trikafta

303529

CF Canada Urges Adoption of New Care Guidelines, Access to Trikafta

Cystic Fibrosis Canada (CFC) is calling on provinces and territories across the country to adopt the latest standardized care guidelines and speed patient access to Trikafta, a triple-combination and “highly impactful” disease-modifying therapy for almost all with cystic fibrosis (CF). The guidelines, “Initiation, Monitoring and Discontinuation of CFTR Modulator Therapies for Patients with Cystic Fibrosis,” were an initiative of Cystic Fibrosis Canada’s healthcare advisory council to provide CF clinicians across Canada with key information regarding the…

You must be logged in to read/download the full post.